Purinoceptor modulation of noradrenaline release in rat tail artery: tonic modulation mediated by inhibitory P2Y‐ and facilitatory A2A‐purinoceptors
Open Access
- 1 January 1996
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 117 (1) , 156-160
- https://doi.org/10.1111/j.1476-5381.1996.tb15168.x
Abstract
1 The effects of analogues of adenosine and ATP on noradrenaline release elicited by electrical stimulation (5 Hz, 2700 pulses) were studied in superfused preparations of rat tail artery. The effects of purinoceptor antagonists, of adenosine deaminase and of adenosine uptake blockade were also examined. Noradrenaline was measured by h.p.l.c. electrochemical detection. 2 The A1-adenosine receptor agonist, N6-cyclopentyladenosine (CPA; 0.1 − 100 nM) reduced, whereas the A2A-receptor agonist 2-p-(2-carboxyethyl)phenethylamino-5′-N-ethylcarboxamidoadenosine (CGS 21680; 3 − 30 nM) increased evoked noradrenaline overflow. These effects were antagonized by the A1-adenosine receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 20 nM) and the A2-adenosine receptor antagonist, 3,7-dimethyl-1-propargylxanthine (DMPX; 100 nM), respectively. The P2Y-purinoceptor agonist, 2-methylthio-ATP (1 − 100 μm) reduced noradrenaline overflow, an effect prevented by the P2-purinoceptor antagonist, cibacron blue 3GA (100 μm) and suramin (100 μm). 3 Adenosine deaminase (2 u ml−1), DMPX (100 nM) and inhibition of adenosine uptake with S-(p-nitrobenzyl)-6-thioinosine (NBTI; 50 nM) decreased evoked noradrenaline overflow. DPCPX alone did not change noradrenaline overflow but prevented the inhibition caused by NBTI. The P2Y-purinoceptor antagonist, cibacron blue 3GA (100 μm) increased evoked noradrenaline overflow as did suramin, a non-selective P2-antagonist. 4 It is concluded that, in rat tail artery, inhibitory (A1 and P2Y) and facilitatory (A2A) purinoceptors are present and modulate noradrenaline release evoked by electrical stimulation. Endogenous purines tonically modulate noradrenaline release through activation of inhibitory P2Y and facilitatory A2A purinoceptors, whereas a tonic activation of inhibitory A1 purinoceptors seems to be prevented by adenosine uptake.Keywords
This publication has 41 references indexed in Scilit:
- P2 purinoceptors modulating noradrenaline release from sympathetic neurons in cultureEuropean Journal of Pharmacology, 1994
- Prejunctional modulation of noradrenaline release in mouse and rat vas deferens: contribution of P1- and P2-purinoceptorsBritish Journal of Pharmacology, 1993
- Axon terminal P2-purinoceptors in feedback control of sympathetic transmitter releaseNeuroscience, 1993
- Excitatory effects of adenosine 5′-triphosphate on rat locus coeruleus neuronesEuropean Journal of Pharmacology, 1992
- The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8‐substituted xanthinesBritish Journal of Pharmacology, 1990
- Subsensitivity of presynaptic adenosine A1-receptors in caudal arteries of spontaneously hypertensive ratsEuropean Journal of Pharmacology, 1989
- Autoregulation of neuromuscular transmission in the guinea-pig saphenous arteryEuropean Journal of Pharmacology, 1987
- Analogs of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptorsJournal of Medicinal Chemistry, 1986
- N6-Cycloalkyladenosines. Potent, A1-selective adenosine agonistsJournal of Medicinal Chemistry, 1985
- Adenosine modulates depolarization-induced release of 3H-noradrenaline from slices of rat brain neocortexEuropean Journal of Pharmacology, 1978